Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Posttraumatic stress disorder (PTSD) and alcohol/substance use disorder (A/SUD) are frequently comorbid. Comorbidity is associated with poorer psychological, functional, and treatment outcomes than either disorder alone. This review outlines biological mechanisms that are potentially involved in the development and maintenance of comorbid PTSD and A/SUD including neurotransmitter and hypothalamic-pituitary-adrenal dysregulation, structural differences in the brain, and shared genetic risk factors. The literature regarding pharmacological treatments that have been investigated for comorbid PTSD and A/SUD is also reviewed. Empirical data for each proposed mechanism and pharmacological approach is reviewed with the goal of making recommendations for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721 · cited 1×
“Elevated levels of CRH have been found in humans going through withdrawal (Adinoff et al., 1996) and in adults with PTSD (Baker et al., 1999; Bremner et al., 1997).”
BackgroundNonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological Considerations
Schottenbauer, M. A., Glass, C. R., Arnkoff, D. B., Tendick, V., & Gray, S. H. (2008) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2008.71.2.134 · Cited by 634 · cited 1×
“In addition, studies of PTSD and/or A/SUD have high dropout rates from research (Dutra et al., 2008; Schottenbauer et al., 2008) However, prospective studies using multiple and comprehensive methods of assessment are needed to further our understanding of the complex interplay of these disorders.”
BackgroundCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · cited 1×
“Koob (1999) suggested the interaction between CRH and the noradrenergic system may mediate hyperarousal symptoms in PTSD. Individuals with PTSD may be drawn to substance use in an attempt to attenuate this feedforward cycle to reduce the activity of the locus ceruleus (Kosten and Krystal, 1988).”
BackgroundThe Dopamine D2 Receptor Locus as a Modifying Gene in Neuropsychiatric Disorders
Comings, D. E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470130073032 · Cited by 587 · cited 3×
“Comings et al. (1991) examined the relationship between a variant in the dopamine receptor gene (DRD2) and comorbid PTSD and A/SUD, and reported that the presence of TaqI A1 allele was not associated with PTSD and AUD.”
BackgroundInfluentialPiazza, P. V., Deminiere, J. M., le Moal, M., & Simon, H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90431-a · Cited by 565
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Baker, D. G., West, S. A., Nicholson, W. E., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Bruce, A. B., Orth, D. N., & Geracioti, T. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.585 · Cited by 531
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519 · cited 1×
“There is evidence supporting the use of selective serotonin reuptake inhibitors (SSRIs) for reducing symptoms of PTSD across multiple RCTs; however, overall effect sizes are small (Ravindran and Stein, 2009; Stein et al., 2006).”
BackgroundBrain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388 · cited 2×
“In the substance use literature, stress experienced in the context of withdrawal is thought to release norepinephrine (Koob, 2009).”
BackgroundShaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C.-D., & Stewart, J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02605.1997 · Cited by 308
Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Brady, K., Weiss, R. D., Farrer, L., & Gelernter, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.153 · Cited by 264 · cited 6×
“3.5.3 SSRIs—Serotonin has been implicated in symptoms and disorders associated with both PTSD and A/SUD including depressed mood, irritability, and arousal (Gilpin and Koob, 2008; Xie et al., 2009).”
BackgroundInfluentialCourse and treatment of patients with both substance use and posttraumatic stress disorders
Ouimette, P. C., Brown, P. J., & Najavits, L. M. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00064-1 · Cited by 245
Genetic and Environmental Predictors of Early Alcohol Use
Kaufman, J., Yang, B.-Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Krystal, J. H., & Gelernter, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.039 · Cited by 216
Pharmacotherapy of PTSD: premises, principles, and priorities.
Ravindran, L. N., & Stein, M. B. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.037 · Cited by 153
The Neuroendocrinology of Posttraumatic Stress Disorder: New Directions
Rasmusson, A. M., Vythilingam, M., & Morgan, C. A. (2003) · CNS Spectrums · doi:10.1017/s1092852900008841 · Cited by 144 · cited 2×
“Abnormalities in this neuroendocrine system have been found in both PTSD and A/SUD (Jacobsen et al., 2001; Lovallo, 2006; Rasmusson et al., 2003) the overlap in HPA involvement may constitute a neurobiological mechanism underlying the comorbidity of these disorders (Jacobsen et al., 2001).”
BackgroundInfluentialKoenen, K. C., Lyons, M. J., Goldberg, J., Simpson, J., Williams, W. M., Toomey, R., Eisen, S. A., True, W., & Tsuang, M. T. (2003) · Journal of Traumatic Stress · doi:10.1023/a:1025786925483 · Cited by 88 · cited 2×
“Koenen et al. (2003) reported that combat exposure was significantly associated with increased risks for both alcohol and cannabis dependence above and beyond PTSD diagnosis.”
BackgroundInfluentialHedges, D. W., Allen, S., Tate, D. F., Thatcher, G. W., Miller, M. J., Rice, S. A., Cleavinger, H. B., Sood, S., & Bigler, E. D. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00003 · Cited by 80
Posttraumatic Stress Disorder and Cocaine Dependence: Order of Onset
Brady, K. T., Dansky, B. S., Sonne, S. C., & Saladin, M. E. (1998) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00327.x · Cited by 67
The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response
Brady, K. T., Waldrop, A. E., Mcrae, A. L., Back, S. E., Saladin, M. E., Upadhyaya, H. P., Anton, R. F., & Randall, P. K. (2006) · Journal of Studies on Alcohol · doi:10.15288/jsa.2006.67.700 · Cited by 51 · cited 3×
“…in both PTSD and A/SUD (Jacobsen et al., 2001), it follows that individuals with both disorders may exhibit greater neuroendocrine dysregulation (Brady et al., 2006b) and/or that a stronger relationship between stress response and alcohol/drug use may be seen in both disorders compared to…”
Background
Cited by
Torchalla, I., Nosen, L., Rostam, H., & Allen, P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.09.001 · Cited by 174
Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09475 · Cited by 145
Post-traumatic psychiatric disorders: PTSD is not the only diagnosis
Auxéméry, Y. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2017.12.006 · Cited by 122
Hien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010071 · Cited by 99
Epigenetic alterations of the BDNF gene in combat‐related post‐traumatic stress disorder
Kim, T. Y., Kim, S. J., Chung, H. G., Choi, J. H., Kim, S. H., & Kang, J. I. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12675 · Cited by 76
“According to the common factors hypothesis, the association between PTSD and alcohol use disorders would be attributable to shared biological vulnerability factors (53).”
Background
Metadata
- Authors
- Norman, S. B., Myers, U. S., Wilkins, K. C., Goldsmith, A. A., Hristova, V., Huang, Z., McCullough, K. C., & Robinson, S. K.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 62
- Issue
- 2
- Pages
- 542-551
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2136230152
- Cited by
- 96
- References
- 22
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.